Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers.
Fiche publication
Date publication
juillet 2024
Journal
European journal of cancer (Oxford, England : 1990)
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOUVIER Anne-Marie, Dr JOOSTE Valérie, Pr LEPAGE Côme
Tous les auteurs :
Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Maso LD, Lepage C, Molinié F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V,
Lien Pubmed
Résumé
To estimate net survival and cancer cure fraction (CF), i.e. the proportion of patients no longer at risk of dying from cancer progression/relapse, a clear distinction needs to be made between mortality from cancer and from other causes. Conventionally, CF is estimated assuming no excess mortality compared to the general population.
Mots clés
Breast cancer, Colorectal cancer, Cure fraction, Head and neck cancer, Increased risk of non-cancer mortality, Mixture cure model, Population based cancer registry
Référence
Eur J Cancer. 2024 07 9;208:114187